Fine-Tuning Breast Cancer Treatments: What Works Better?
Studies compared side effects with different Taxol schedules, and between radiation and surgeryContinue Reading
Studies compared side effects with different Taxol schedules, and between radiation and surgeryContinue Reading
Researchers say finding underscores need for DNA screeningContinue Reading
American pediatricians address needs, concerns of Hispanic parentsContinue Reading
Lambrolizumab activates body’s immune system to kill cancerous cells, researchers sayContinue Reading
Sorafenib appeared to delay disease progression, shrink tumors in early studyContinue Reading
Study found it prolonged remission after chemotherapy almost six months longer than a placeboContinue Reading
In preliminary trial, nivolumab shrank tumors in 30 percent of tough-to-treat patientsContinue Reading
Inadequate post-op rehab might be a factor, study authors sayContinue Reading
Medication activates areas associated with the disorder, scans showContinue Reading
Latest technology lets you jog along with zombies, bulls and race carsContinue Reading
Tumor growth suppressed in lab tests; human trials still needed, study authors sayContinue Reading
Report found those on Medicaid were more likely to do so than the uninsured, privately insuredContinue Reading
Delicate balance exists between treating anemia, avoiding side effects from infusion of red blood cells, study saysContinue Reading
Memory chips help prevent release of unwanted productsContinue Reading
© 2021 TheHealthCast.com - All Rights Reserved.